Thiazolidine → HCID 927517, compound
Reaction equation
Br[CH2:2][CH2:3][C:4]1[C:12]2[C:7](=[CH:8][CH:9]=[CH:10][CH:11]=2)[NH:6][CH:5]=1.[S:13]1[CH2:17][CH2:16][NH:15][CH2:14]1>C(Cl)(Cl)Cl>[NH:6]1[C:7]2[C:12](=[CH:11][CH:10]=[CH:9][CH:8]=2)[C:4]([CH2:3][CH2:2][N:15]2[CH2:16][CH2:17][S:13][CH2:14]2)=[CH:5]1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
3-(2-Bromo-ethyl)-indole (3.00 g, 13.4 mmol) and thiazolidine (2.38 g, 26.8 mmol) were stirred in abs. CHCl3 (25 ml) at a bath temperature of 75° C. for 5 h. The mixture was cooled to RT and extracted with dilute sulfuric acid (2×30 ml). The acidic aqueous phase was rendered alkaline with 5N NaOH, while cooling with ice, and extracted with ether (3×30 ml). The organic phase was dried over Na2SO4 and concentrated i. vac. and the residue was purified by flash chromatography with CHCl3/MeOH (20:1→4:1→MeOH).
Workup
- extractionextracted with dilute sulfuric acid (2×30 ml)
- temperaturewhile cooling with ice
- extractionextracted with ether (3×30 ml)
- dry with materialThe organic phase was dried over Na2SO4
- concentrationconcentrated i
- customand the residue was purified by flash chromatography with CHCl3/MeOH (20:1→4:1→MeOH)
Sources & evidence
- ORD record
- ord-5a5f34f358494d0a8b52adbe72d0a080
- Source dataset
- uspto-grants-2012_03
- Patent number
- US08138187B2
Reaction notes
Loading…